MetaCap

Boundless Bio Statistics

NASDAQ: BOLDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.63-0.01 (-0.38%)

Market open · Delayed 15 min · as of Oct 8, 10:14 AM ET

Boundless Bio by the numbers

Boundless Bio has a market capitalization of $59.8 million based on 22.75M shares outstanding. With trailing EPS of $-2.85, Boundless Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.0% below its 50-day average and 45.3% above its 200-day average.

Average daily trading volume is 179.14K shares, or about $471,136 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BOLD valuation vs. peer median

BOLD compared with the median of 8 peer companies
MetricBOLDPeer medianDifference
Market cap$59.83M$59.46M+1%
Avg. volume179.14K613.81K-71%

Peer median across 8 companies: RNXT, CNTB, PLRX, XLO, MREO, GOSS, IBIO, ATHE.

Valuation

Market cap
$59.83M
P/E (TTM)
—
Forward P/E
—
EPS (TTM)
$-2.85
Shares outstanding
22.75M

Price and trading

Previous close
2.64
Open
2.58
Day range
2.58 – 2.67
52-week range
0.961 – 3.16
52-week change
+114.63%
50-day moving average
2.77
200-day moving average
1.81
Beta
—
Volume
36.42K
Average volume
179.14K

Dividends and events

Annual dividend
None
Dividend yield
—
Ex-dividend date
—
Next earnings date
Nov 4, 2026

Additional statistics

Market Cap
59.83M
Forward Pe
-2.68
Eps
-2.85
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.16
Week52 Low
0.96
Avg Volume
179.14K
Shares Outstanding
22.75M
Ma50
2.77
Ma200
1.81
Earnings Date
Nov 4, 2026
Pct From52w High
-16.88%
Pct From52w Low
173.67%

Related